Dosage form for treating severe asthma
Abstract:
Methods are provided for treating corticosteroid-resistant asthma in a patient, comprising decreasing Interferon Regulatory Factor 5 (IRF5) activity in the patient. Antisense or RNA interference reagents and methods can be used to decrease IRF5 activity in the patient.
Public/Granted literature
Information query
Patent Agency Ranking
0/0